The major workforce overhaul comes a month after parent company Roche deemed the cell and gene therapy firm a financial loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback